• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Aspen API. More than just an API™

    China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill

    BIOSPACE

    Corxel secures $287M series D to fund oral GLP-1 studies

    ENDPOINTS

    LENZ Therapeutics Submits NDA for LNZ100 to NMPA in China

    GLOBENEWSWIRE

    ADA 2025: Phase 2 CX11/VCT220 Trial Data in China Revealed

    GLOBENEWSWIRE

    Corxel Gets FDA Approval for Phase 2 Trial of CX11 in Obesity

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.